Latest Breaking News On - Prnewswire hagens berman - Page 18 : vimarsana.com

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm s Attorneys Now, Securities Fraud Case Filed

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm s Attorneys Now, Securities Fraud Case Filed News provided by Share this article Share this article SAN FRANCISCO, June 28, 2021 /PRNewswire/ Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class action has been filed and certain investors may have valuable claims. Class Period: Sept. 18, 2020 - June 17, 2021 Lead Plaintiff Deadline: Aug. 24, 2021 Contact An Attorney Now: [email protected] Athira Pharma, Inc. (ATHA) Securities Class Action: Since going public in September 2020, Athira and senior management have repeatedly emphasized the importance of CEO Leen Kawas doctoral research to the company s product candidates intended to treat Alzheimer s.

Prnewswire hagens bermanPaul matteisHagens bermanReed kathreinAthira pharma incWashington state universityHagens berman sobol shapiroAthira pharmaPlaintiff deadlineSecurities class actionWashington stateBerman sobol shapiroபால் மாத்தேச்கென்ஸ் பெர்மன்அதிரா பார்மா இன்க்வாஷிங்டன் நிலை பல்கலைக்கழகம்

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm s Attorneys Now, Firm Investigating Possible Securities Law Violations

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm s Attorneys Now, Firm Investigating Possible Securities Law Violations
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Prnewswire hagens bermanPaul matteisHagens bermanReed kathreinAthira pharma incWashington state universityHagens berman sobol shapiroAthira pharmaLeen kawasWashington stateBerman sobol shapiroபால் மாத்தேச்கென்ஸ் பெர்மன்அதிரா பார்மா இன்க்வாஷிங்டன் நிலை பல்கலைக்கழகம்கென்ஸ் பெர்மன் சோபோல் ஷாபிரோ

PTON DEADLINE ALERT: HAGENS BERMAN, National Trial Attorneys, Alerts Peloton Interactive (PTON) Investors to Filing of Securities Class Action, Advises Investors with Losses to Contact the Firm Now

Peloton Interactive, Inc. (NASDAQ: PTON) Securities Fraud Class Action: The complaint alleges Peloton misled investors by misrepresenting and concealing that (1) Peloton was focused on safety, (2) Peloton s Tread+ caused a serious safety threat to children and pets as there were multiple incidents of injury to both, including death, and (3) despite knowledge of the dangers posed by Tread+, defendants did not recall or suggest halting its use. Investors began to learn the truth on Apr. 17, 2021, when the U.S. Consumer Product Safety Commission urgently warned consumers to stop using the Tread+ after finding one death and dozens of incidents of children being sucked under the Tread+. The next day, CEO John Foley announced Peloton had no intention of recalling or to stop selling the Tread+, calling the CPSC s warning inaccurate and misleading.

Prnewswire hagens bermanJohn foleyHagens bermanReed kathreinPeloton interactive incHagens berman sobol shapiroUs consumer product safety commissionPeloton interactivePlaintiff deadlineSecurities fraud class actionProduct safety commissionBerman sobol shapiroஜான் ஃபோலீகென்ஸ் பெர்மன்பெலடாந் ஊடாடும் இன்க்கென்ஸ் பெர்மன் சோபோல் ஷாபிரோ

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages PureCycle Technologies (PCT) Investors to Contact Firm s Attorneys Now, Firm Investigating Possible Securities Law Violations

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages PureCycle Technologies (PCT) Investors to Contact Firm s Attorneys Now, Firm Investigating Possible Securities Law Violations News provided by Share this article Share this article SAN FRANCISCO, May 7, 2021 /PRNewswire/ Hagens Berman urges PureCycle Technologies, Inc. (NASDAQ: PCT) investors with significant losses to submit your losses now. The firm is investigating possible securities fraud and certain investors may have valuable claims. Contact An Attorney Now: [email protected] PureCycle Technologies, Inc. (NASDAQ: PCT) Investigation: The investigation focuses on PureCycle s repeated claims that it is an environmental, social and governance ( ESG ) company. PureCycle and its management have repeatedly claimed the company is commercializing a patented purification recycling technology developed by The Proctor & Gamble

Prnewswire hagens bermanHagens bermanReed kathreinPurecycle technologies incProctor gamble companyHagens berman sobol shapiroHindenburg researchPurecycle technologiesCycle technologiesGamble companyLatest zero revenueBerman sobol shapiroகென்ஸ் பெர்மன்ப்ராக்டர் சூதாட்டம் நிறுவனம்கென்ஸ் பெர்மன் சோபோல் ஷாபிரோஹிண்டன்பர்க் ஆராய்ச்சி

CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud

ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action: The lawsuit focuses on ChemoCentryx s statements about its new drug application ( NDA ) for its vasculitis drug candidate Avacopan. Beginning on Nov. 25, 2019, ChemoCentryx touted positive topline data from its Pivotal Phase III ADVOCATE trial demonstrating Avacopan s superiority over standard of care in ANCA-associated vasculitis and that the trial met both of its primary endpoints. This and subsequent positive announcements sent the price of CCXI soaring. The complaint alleges ChemoCentryx concealed that: (1) the trial s study design was flawed; (2) data from the trial raised serious safety concerns; and (3) these issues presented a substantial concern about the viability of ChemoCentryx s NDA.

Prnewswire hagens bermanHagens bermanReed kathreinHagens berman sobol shapiroChemocentryx incPlaintiff deadlineSecurities fraud class actionPivotal phaseBerman sobol shapiroகென்ஸ் பெர்மன்கென்ஸ் பெர்மன் சோபோல் ஷாபிரோபத்திரங்கள் மோசடி வர்க்கம் நடவடிக்கைமுக்கிய கட்டம்பெர்மன் சோபோல் ஷாபிரோ